EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"Adverse-reaction-monitoring"
Narrow search

Narrow search

Year of publication
Subject
All
Adverse-reaction-monitoring 6 Cost-analysis 4 Pharmacoeconomics 4 Reviews-on-treatment 3 Analgesics 2 Antibacterials 2 Adverse reaction monitoring 1 Aminoglycosides 1 Anaphylaxis 1 Antiasthmatics 1 Anticoagulants 1 Antidepressants 1 Antineoplastics 1 Antipsychotics 1 Computers 1 Contrast-media 1 Digoxin 1 Drug information services 1 Drug-hypersensitivity 1 Hospitalisation 1 Kidney-disorders 1 Medical-education 1 Mortality 1 NSAID-induced-gastrointestinal-damage 1 Neuromuscular-blockers 1 Nonsteroidal-anti-inflammatories 1 Opioid-agonists 1 Pain 1 Patient-controlled-analgesia 1 Patient-education 1 Postoperative-pain 1 Practice-guideline-commentary 1 Questionnaires 1 Schizophrenia 1 Surgery 1
more ... less ...
Online availability
All
Undetermined 7
Type of publication
All
Article 7
Language
All
Undetermined 7
Author
All
Rho, Jay P. 2 Arakelian, Annet 1 Beringer, Paul M. 1 Campbell, Lynne 1 Cappelletty, Diane M. 1 Crockell, Yvette J. 1 Dassori, Albana M. 1 England, Nancy P. 1 Lyon, Ronald A. 1 Miller, Alexander L. 1 Otero, Maria Jose 1 Plummer, John 1 Rodriguez-Monguio, Rosa 1 Rovira, Joan 1 Slaughter, Richard L. 1 Weiden, Peter J. 1 White, T. Jeffrey 1 Wong-Berringer, Annie 1
more ... less ...
Published in...
All
PharmacoEconomics 4 Disease Management and Health Outcomes 3
Source
All
RePEc 7
Showing 1 - 7 of 7
Cover Image
The Approaches to Schizophrenia Communication (ASC) Tool: Including the Patient Perspective in Treatment
Dassori, Albana M.; Miller, Alexander L.; Weiden, Peter J. - In: Disease Management and Health Outcomes 11 (2003) 11, pp. 699-708
Adverse effects of antipsychotics are important determinants of patient attitudes towards medications, adherence to treatment, and quality of life. A discussion of adverse effects is therefore a crucial element of treatment and offers a unique opportunity for dialogue between the patient and the...
Persistent link: https://www.econbiz.de/10005404614
Saved in:
Cover Image
Assessing the Economic Impact of Adverse Drug Effects
Rodriguez-Monguio, Rosa; Otero, Maria Jose; Rovira, Joan - In: PharmacoEconomics 21 (2003) 9, pp. 623-650
Although most commonly used drugs cause adverse effects, some of them with potentially serious consequences, relatively little is known about their economic impact. The purpose of this review is to summarise information describing the cost of treatment of drug-induced adverse effects as an...
Persistent link: https://www.econbiz.de/10005404829
Saved in:
Cover Image
Counting the Costs of Drug-Related Adverse Events
White, T. Jeffrey; Arakelian, Annet; Rho, Jay P. - In: PharmacoEconomics 15 (1999) 5, pp. 445-458
Adverse drug events occur frequently and lead to a significant number of fatalities each year. It has been estimated that fatalities directly attributable to adverse drug reactions are the fourth to sixth leading cause of death in US hospitals, exceeding deaths caused by pneumonia and diabetes....
Persistent link: https://www.econbiz.de/10005449050
Saved in:
Cover Image
Economic Aspects of Antibacterial Adverse Effects
Beringer, Paul M.; Wong-Berringer, Annie; Rho, Jay P. - In: PharmacoEconomics 13 (1998) 1 Part 1, pp. 35-49
The economic impact of adverse effects is often understated. Increased hospitalisations attributed to adverse drug reactions alone account for billions of dollars each year within the US healthcare system. Although most classes of antibacterials are well tolerated, severe reactions do occur and...
Persistent link: https://www.econbiz.de/10005449000
Saved in:
Cover Image
Guidelines for the Implementation of Patient-Controlled Analgesia
Campbell, Lynne; Plummer, John - In: Disease Management and Health Outcomes 4 (1998) 1, pp. 27-39
Intravenous patient-controlled analgesia (PCA) can provide improved postoperative pain control compared with traditional methods, while maintaining safety. However, poorly managed PCA cannot be expected to provide good analgesia and may increase the risk of adverse events. Effective use of PCA...
Persistent link: https://www.econbiz.de/10005243034
Saved in:
Cover Image
Economic Impact of Aminoglycoside Toxicity and its Prevention Through Therapeutic Drug Monitoring
Slaughter, Richard L.; Cappelletty, Diane M. - In: PharmacoEconomics 14 (1998) 4, pp. 385-394
Therapeutic drug monitoring (TDM) of aminoglycoside antibacterials with the goal of minimising toxicity and maximising effectiveness has become routine. Successful management of serious infections requires the ability to achieve therapeutic peak concentrations, while maintaining low trough...
Persistent link: https://www.econbiz.de/10005243124
Saved in:
Cover Image
Computer-Assisted Drug Therapy Problem Notification
Lyon, Ronald A.; Crockell, Yvette J.; England, Nancy P. - In: Disease Management and Health Outcomes 7 (2000) 5, pp. 245-250
Objective: To describe the use of computer technology to enhance our ability to identify and notify providers of potential drug therapy problems using a mail intervention monitoring programme. Setting: Pharmacy benefit management company. Intervention: Use of clinical software systems and...
Persistent link: https://www.econbiz.de/10005590110
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...